Branko Miladinovic

Summary

Affiliation: University of South Florida
Country: USA

Publications

  1. ncbi request reprint External validation of a web-based prognostic tool for predicting survival for patients in hospice care
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, Morsani College of Medicine, University of South Florida, 3515 E Fletcher Avenue, MDT1200, Mail Code MDC27, Tampa, Florida 33612, USA
    J Palliat Care 29:140-6. 2013
  2. doi request reprint Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random error
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, Department of Internal Medicine, Clinical and Translational Science Institute, Morsani College of Medicine, University of South Florida, 3515 East Fletcher Avenue, MDC 27, Tampa, FL 33612, USA
    J Clin Epidemiol 66:654-9. 2013
  3. doi request reprint Trial sequential analysis may be insufficient to draw firm conclusions regarding statistically significant treatment differences using observed intervention effects: a case study of meta-analyses of multiple myeloma trials
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, FL, USA
    Contemp Clin Trials 34:257-61. 2013
  4. pmc A flexible alternative to the Cox proportional hazards model for assessing the prognostic accuracy of hospice patient survival
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, Florida, USA
    PLoS ONE 7:e47804. 2012
  5. pmc Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-compliance
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, FL, USA
    BMC Med Res Methodol 11:55. 2011
  6. doi request reprint Bisphosphonates in multiple myeloma: a network meta-analysis
    Rahul Mhaskar
    Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, Florida, USA
    Cochrane Database Syst Rev 5:CD003188. 2012
  7. pmc How do physicians decide to treat: an empirical evaluation of the threshold model
    Benjamin Djulbegovic
    Department of Internal Medicine, Division of Evidence Based Medicine and Health Outcomes Research, University of South Florida, Tampa, FL, USA
    BMC Med Inform Decis Mak 14:47. 2014
  8. pmc Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials
    Benjamin Djulbegovic
    Center for Evidence based medicine and Health Outcomes Research, Tampa, Florida, USA
    PLoS ONE 8:e58711. 2013
  9. pmc Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis
    Hesborn Wao
    Center for Evidence Based Medicine and Outcomes Research, Department of Internal Medicine, Morsani College of Medicine, University of South Florida Clinical and Translational Science Institute, 3515 East Fletcher Avenue, MDT 1202, Tampa, FL, 33612, USA
    Syst Rev 2:10. 2013
  10. ncbi request reprint Defining optimum treatment of patients with pancreatic adenocarcinoma using regret-based decision curve analysis
    Jonathan M Hernandez
    Department of Surgery, Division of General Surgery, University of South Florida, Tampa, FL Center for Evidence Based Medicine, University of South Florida, Tampa, FL Department of Internal Medicine, Division of Evidence Based Medicine, Tampa, FL Department of Hematology and Health Outcomes and Behavior, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
    Ann Surg 259:1208-14. 2014

Collaborators

Detail Information

Publications14

  1. ncbi request reprint External validation of a web-based prognostic tool for predicting survival for patients in hospice care
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, Morsani College of Medicine, University of South Florida, 3515 E Fletcher Avenue, MDT1200, Mail Code MDC27, Tampa, Florida 33612, USA
    J Palliat Care 29:140-6. 2013
    ..If it is to be useful to patients and clinicians, Prognostat needs to explicitly report patient risk scores and estimates of baseline survival...
  2. doi request reprint Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random error
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, Department of Internal Medicine, Clinical and Translational Science Institute, Morsani College of Medicine, University of South Florida, 3515 East Fletcher Avenue, MDC 27, Tampa, FL 33612, USA
    J Clin Epidemiol 66:654-9. 2013
    ..We conducted a TSA for time-to-event outcomes and applied the method to determine the risk of random error in MAs for treatments of multiple myeloma...
  3. doi request reprint Trial sequential analysis may be insufficient to draw firm conclusions regarding statistically significant treatment differences using observed intervention effects: a case study of meta-analyses of multiple myeloma trials
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, FL, USA
    Contemp Clin Trials 34:257-61. 2013
    ..We recommend that the conclusion of significant treatment differences in cumulative MA should be weighed against acceptable thresholds regarding the type I error, power and apriori specified clinically meaningful treatment difference...
  4. pmc A flexible alternative to the Cox proportional hazards model for assessing the prognostic accuracy of hospice patient survival
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, Florida, USA
    PLoS ONE 7:e47804. 2012
    ..Researchers involved in prognosticating patient survival are encouraged to consider the Royston-Parmar model as an alternative to Cox...
  5. pmc Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-compliance
    Branko Miladinovic
    Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, FL, USA
    BMC Med Res Methodol 11:55. 2011
    ..Our objective is to correct for bias in non-experimental data from previously published individual patient data meta-analysis by applying IV methods..
  6. doi request reprint Bisphosphonates in multiple myeloma: a network meta-analysis
    Rahul Mhaskar
    Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, Florida, USA
    Cochrane Database Syst Rev 5:CD003188. 2012
    ..This is an update of a Cochrane review first published in 2002 and previously updated in 2010...
  7. pmc How do physicians decide to treat: an empirical evaluation of the threshold model
    Benjamin Djulbegovic
    Department of Internal Medicine, Division of Evidence Based Medicine and Health Outcomes Research, University of South Florida, Tampa, FL, USA
    BMC Med Inform Decis Mak 14:47. 2014
    ....
  8. pmc Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials
    Benjamin Djulbegovic
    Center for Evidence based medicine and Health Outcomes Research, Tampa, Florida, USA
    PLoS ONE 8:e58711. 2013
    ..To assess if commercially sponsored trials are associated with higher success rates than publicly-sponsored trials...
  9. pmc Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis
    Hesborn Wao
    Center for Evidence Based Medicine and Outcomes Research, Department of Internal Medicine, Morsani College of Medicine, University of South Florida Clinical and Translational Science Institute, 3515 East Fletcher Avenue, MDT 1202, Tampa, FL, 33612, USA
    Syst Rev 2:10. 2013
    ..Specifically, we estimated overall survival when no anticancer therapy is provided...
  10. ncbi request reprint Defining optimum treatment of patients with pancreatic adenocarcinoma using regret-based decision curve analysis
    Jonathan M Hernandez
    Department of Surgery, Division of General Surgery, University of South Florida, Tampa, FL Center for Evidence Based Medicine, University of South Florida, Tampa, FL Department of Internal Medicine, Division of Evidence Based Medicine, Tampa, FL Department of Hematology and Health Outcomes and Behavior, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
    Ann Surg 259:1208-14. 2014
    ..To use regret decision theory methodology to assess three treatment strategies in pancreatic adenocarcinoma...
  11. ncbi request reprint Bisphosphonates in multiple myeloma
    Rahul Mhaskar
    Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, Florida, USA
    Cochrane Database Syst Rev 3:CD003188. 2010
    ..Also, with the baseline risk of 35% to 86% for SREs without treatment, we estimate that between six and 15 MM patients should be treated to prevent SRE(s) in one patient. No bisphoshphonate appears to be superior to others...
  12. pmc New treatments compared to established treatments in randomized trials
    Benjamin Djulbegovic
    USF Clinical Translational Science Institute, Dpts of Medicine, Hematology and Health Outcome Research, USF and H LeeMoffitt Cancer Center, USF Health Clinical Research, University of South Florida, Tampa, Florida, USA
    Cochrane Database Syst Rev 10:MR000024. 2012
    ..We investigated how often new, experimental treatments evaluated in randomized controlled trials (RCTs) are superior to established treatments...
  13. doi request reprint Sequence of novel agents in multiple myeloma: an instrumental variable analysis
    Rachid Baz
    Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
    Leuk Res 37:1077-82. 2013
    ..These findings were confirmed with instrumental variable analyses. Finally, use of bortezomib first was associated with improved survival for patients with baseline renal insufficiency. ..
  14. pmc Do community health worker interventions improve rates of screening mammography in the United States? A systematic review
    Kristen J Wells
    University of South Florida, Tampa, FL 33612, USA
    Cancer Epidemiol Biomarkers Prev 20:1580-98. 2011
    ..Community health workers (CHW) are lay individuals who are trained to serve as liaisons between members of their communities and health care providers and services...